Advanced Biomed ADVB
NASDAQ ADVB
$6.86 -0.17 (-2.42%)
As of: Oct 2, 2026 · 9:32 AM EDT

Advanced Biomed (ADVB) Accumulated Expenses (2025 - 2026)

Updated

Advanced Biomed (ADVB) recorded Accumulated Expenses of $238,538 in fiscal Q3 2026 (quarter ended Mar 31, 2026), up 6.5% from the prior quarter.

Analysis

Advanced Biomed (ADVB) Accumulated Expenses (2025 - 2026) Analysis & Trends

At the end of FY2025 (ended Jun 30, 2025), Advanced Biomed reported Accumulated Expenses of $575,831.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn
10 Advanced Biomed 8.61 Mn 8.61 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 238,538.00
Dec 31, 2025 224,038.00
Jun 30, 2025 575,831.00
API Access

Advanced Biomed Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=ADVB&period=max&api_key=YOUR_API_KEY